Literature DB >> 19723140

Differences in genetic instability and cellular phenotype among Barrett's, cardiac, and gastric intestinal metaplasia in a Japanese population with Helicobacter pylori.

Jiro Watari1, Kentaro Moriichi, Hiroki Tanabe, Ryu Sato, Mikihiro Fujiya, Hiroto Miwa, Kiron M Das, Yutaka Kohgo.   

Abstract

AIMS: Intestinal metaplasia is considered to be a precursor lesion in both Barrett's and intestinal-type gastric cancer. The aim was to clarify the differences in molecular pathology between specialized intestinal metaplasia (SIM) in Barrett's oesophagus (BO), cardiac (CIM) and gastric intestinal metaplasia (GIM). METHODS AND
RESULTS: Eighty-eight SIM cases with BO, 30 CIM cases and 52 GIM cases in patients with or without Helicobacter pylori infectionwere analysed for genetic instability and Das-1. Microsatellite instability and a loss of heterozygosity were evaluated at five microsatellite loci. The incidence of genetic instability was 55.7% in SIM, 40.0% in CIM and 23.1% in GIM, revealing a significant difference between SIM and GIM (P < 0.0005). For each microsatellite marker analysed, there were obvious differences in frequency among the three conditions. Das-1 reactivity was significantly higher in SIM than in CIM or GIM (P < 0.0001, both). Interestingly, both genetic instability and Das-1 reactivity in SIM showed a significantly higher incidence in patients with H. pylori infection than in those without (P < 0.005 and P < 0.01, respectively).
CONCLUSIONS: SIM is distinct from CIM and GIM, and the pathogenesis of SIM, like that of GIM, is associated to some degree with H. pylori infection in a Japanese population.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19723140      PMCID: PMC4458565          DOI: 10.1111/j.1365-2559.2009.03370.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  70 in total

1.  Microsatellite instability and the clinicopathological features of sporadic colorectal cancer.

Authors:  R Ward; A Meagher; I Tomlinson; T O'Connor; M Norrie; R Wu; N Hawkins
Journal:  Gut       Date:  2001-06       Impact factor: 23.059

Review 2.  Is there publication bias in the reporting of cancer risk in Barrett's esophagus?

Authors:  N J Shaheen; M A Crosby; E M Bozymski; R S Sandler
Journal:  Gastroenterology       Date:  2000-08       Impact factor: 22.682

Review 3.  Genetic and epigenetic changes in stomach cancer.

Authors:  H Yokozaki; W Yasui; E Tahara
Journal:  Int Rev Cytol       Date:  2001

Review 4.  Review article: Barrett's oesophagus and carcinoma in Japan.

Authors:  M Hongo
Journal:  Aliment Pharmacol Ther       Date:  2004-12       Impact factor: 8.171

5.  Effects of Helicobacter pylori infection on genetic instability, the aberrant CpG island methylation status and the cellular phenotype in Barrett's esophagus in a Japanese population.

Authors:  Kentaro Moriichi; Jiro Watari; Kiron M Das; Hiroki Tanabe; Mikihiro Fujiya; Toshifumi Ashida; Yutaka Kohgo
Journal:  Int J Cancer       Date:  2009-03-15       Impact factor: 7.396

Review 6.  Barrett's esophagus: histopathologic definitions and diagnostic criteria.

Authors:  James Mueller; Martin Werner; Manfred Stolte
Journal:  World J Surg       Date:  2004-01-20       Impact factor: 3.352

7.  Clinicopathologic characteristics of replication error-positive gastric carcinoma.

Authors:  G H Kang; G S Yoon; H K Lee; Y M Kwon; J Y Ro
Journal:  Mod Pathol       Date:  1999-01       Impact factor: 7.842

Review 8.  Barrett's esophagus, dysplasia, and adenocarcinoma.

Authors:  R C Haggitt
Journal:  Hum Pathol       Date:  1994-10       Impact factor: 3.466

Review 9.  Helicobacter pylori and gastric carcinogenesis.

Authors:  P Correa
Journal:  Am J Surg Pathol       Date:  1995       Impact factor: 6.394

10.  Molecular mechanism of stomach carcinogenesis.

Authors:  E Tahara
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

View more
  4 in total

1.  The association between Barrett's esophagus and Helicobacter pylori infection: a meta-analysis.

Authors:  Lori A Fischbach; Helena Nordenstedt; Jennifer R Kramer; Subi Gandhi; Sam Dick-Onuoha; Anthony Lewis; Hashem B El-Serag
Journal:  Helicobacter       Date:  2012-03-20       Impact factor: 5.753

2.  Association between obesity and Barrett's esophagus in a Japanese population: a hospital-based, cross-sectional study.

Authors:  Jiro Watari; Kazutoshi Hori; Fumihiko Toyoshima; Noriko Kamiya; Takahisa Yamasaki; Takuya Okugawa; Haruki Asano; Zhao Liang Li; Takashi Kondo; Hisatomo Ikehara; Jun Sakurai; Toshihiko Tomita; Tadayuki Oshima; Hirokazu Fukui; Hiroto Miwa
Journal:  BMC Gastroenterol       Date:  2013-09-26       Impact factor: 3.067

3.  The characterization of an intestine-like genomic signature maintained during Barrett's-associated adenocarcinogenesis reveals an NR5A2-mediated promotion of cancer cell survival.

Authors:  Shane P Duggan; Fiona M Behan; Murat Kirca; Abdul Zaheer; Sarah A McGarrigle; John V Reynolds; Gisela M F Vaz; Mathias O Senge; Dermot Kelleher
Journal:  Sci Rep       Date:  2016-09-02       Impact factor: 4.379

Review 4.  Helicobacter pylori infection reduces the risk of Barrett's esophagus: A meta-analysis and systematic review.

Authors:  Bálint Erőss; Nelli Farkas; Áron Vincze; Benedek Tinusz; László Szapáry; András Garami; Márta Balaskó; Patrícia Sarlós; László Czopf; Hussain Alizadeh; Zoltán Rakonczay; Tamás Habon; Péter Hegyi
Journal:  Helicobacter       Date:  2018-06-25       Impact factor: 5.753

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.